Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Inflammation, Migraine, Musculoskeletal stiffness, Nausea, Pain
Clinical narrative: Immediate blurred vision and stiff neck within 20 mins, within 30 burning pain in wrist, shoulder blade, sciatic nerve, across hip bones/sacroiliac joint.; Immediate blurred vision and stiff neck within 20 mins, within 30 burning pain in wrist, shoulder blade, sciatic nerve, across hip bones/sacroiliac joint.; Immediate blurred vision and stiff neck within 20 mins, within 30 burning pain in wrist, shoulder blade, sciatic nerve, across hip bones/sacroiliac joint.; Within 24 hours, previous ankle injury pain flared up and burning when taking a breath, wheezing and chest pressure.; Within 24 hours, previous ankle injury pain flared up and burning when taking a breath, wheezing and chest pressure.; Within 24 hours, previous ankle injury pain flared up and burning when taking a breath, wheezing and chest pressure.; Within 24 hours, previous ankle injury pain flared up and burning when taking a breath, wheezing and chest pressure.; Numbness in left leg, left side below the knee.; Nausea and gastrointestinal upset that hasnt subsided at day 8.; Previously pinched nerves inflamed and persistent migraine.; Previously pinched nerves inflamed and persistent migraine.; Nausea and gastrointestinal upset that hasnt subsided at day 8.; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO151) via an unspecified route of administration in the left arm on 07Apr2021 at 13:15 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included reactive airways disease, cervical spinal stenosis, myelogram study, drug intolerance (chemical) and ankle injury. The patient previously took meloxicam (MANUFACTURER UNKNOWN) for unspecified indication on an unspecified date and experienced drug intolerance (diagnosed as 'chemical intolerant', adverse reaction to meloxicam). Concomitant medication taken within two weeks of vaccination included multivitamin for unspecified indication since unspecified date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 13:30, the patient experienced immediate blurred vision and stiff neck within 20 mins, within 30 burning pain in wrist, shoulder blade, sciatic nerve, across hip bones/sacroiliac joint. Within 24 hours, on an unknown date in Apr2021, previous ankle injury pain flared up and burning when taking a breath, wheezing and chest pressure. On an unknown date in Apr2021, the patient also had numbness in left leg, left side below the knee. Nausea and gastrointestinal upset that hadn't subsided at day eight. Previously pinched nerves inflamed and persistent migraine. The events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event within 20 mins, immediate blurred vision and stiff neck, within 30 burning pain in wrist, shoulder blade, sciatic nerve, across hip bones/sacroiliac joint, within 24 hours, previous ankle injury pain flared up, burning when taking a breath, wheezing, chest pressure, numbness in left leg, left side below the knee, gastrointestinal upset, previously pinched nerves inflamed, persistent migraine, nausea were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.